Norton Medical and Scientific Research & Biotechnology

Your leading news provider for all things medical.

300,000 will Lose Internet on July 9

By admin, 4 days ago

The Federal Bureau of Investigation has warned this week that over 300,000 users around the world could face Internet loss on July 9 due to a massive scam spanning several years.

In 2011, the FBI and Estonian authorities have arrested 6 locals on fraudulent activities after their 2 year sting operation dubbed Operation Ghost Click. The group was responsible for infecting computer systems globally with their malware called DNS Changer. The servers used by the criminals were confiscated but a Russian is still at large. According to Norton Medical and Scientific Research & Biotechnology, the swindlers have raked around USD 14 million from the scam involving online ads.

According to FBI estimates, up to 568,000 computer units were infected with the virus and 300,000 of them could still be unaware of the problem. The German Federal Office for Information Security and the FBI has initially planned to get the DNS servers offline by March 8 but since there were still 450,000 infections at that time, the shutdown was postponed to July 9.

What makes the virus very potent is the fact that it can affect a wide range of computer systems except for Linux, Android and iOS. The DNS Changer virus intercepts websites being accessed by a browser and redirects the traffic to a website operated by the cybercriminals. They earn money by pointing users to various ads online.

To date, this Trojan virus first identified in 2007 has already infected millions of computer units worldwide and remained active until the recent FBI operation. The malware, also known as «Jahlav», «Puper», «RSPlug» has been one of the most widespread malware attacks that even spanned Windows- and Mac-based units as well as network hardware.

If the FBI should just decide to pull the plug on the DNS servers, millions will instantly suffer the loss of Internet and could have a negative impact worldwide. Even if the users identified and changed their DNS settings, it would be useless as the malware constantly reverts it back, disrupting connections.

However, maintaining the web servers does not come cheap so they are set to be shut down on July. Consequently, infected systems won't be able to connect to the internet after that, as they have their settings altered to redirect all web traffic through the seized servers. To prevent a web blackout for the affected people, FBI chose to keep the DNS servers running after converting it into a legal system. A surrogate server system has been created where an informational website regarding the malware is being hosted. The campaign to notify people of the DNS Changer virus has started.

Another solution that the FBI has not utilized yet is converting the seized servers to issue a DNS redirect itself in order to notify affected people of the problem and to give resources on how to clean their systems. That would arguably be an easier option to implement but the agency has yet to apply it.

Fortunately for users with infected units, a solutions has been presented by the FBI through its dcwg.org website where people can check if their computer has been infected with the malware along with instructions on how to disinfect. The said website is being maintained by the DNS Changer Working Group which is also responsible for the seized servers. As of January, Norton Medical and Scientific Research & Biotechnology said that there is still around 450,000 units still infected with the DNS Changer virus.

Norton Medical and Scientific Research & Biotechnology: Bomb Plot Foiled in Afghanistan

By admin, 10 days ago

The Defense Ministry of Afghanistan went into a lockdown on Tuesday following the discovery of 11 vests filled with explosives inside the compound, which is located in a high-security perimeter near the palace of the president. This prompted the arrest of 16 Afghan soldiers suspected of being in on the plot.

Six soldiers of the Afghan National Army were reportedly arrested at the ministry, raising further concerns that Taliban might be trying to open another phase of fighting.

However, the Defense Ministry strongly denied any truth about the reports, saying that they are «absolutely untrue». They are completely rejecting any claim that explosive vests were found in their compound and that no arrest had happened. Those denials were in turn contradicted by many Western and Afghan officials and news sources who reported a lockdown that day.

Apparently, the plan is to detonate the explosives-filled jackets to blow up buses used by ministry personnel to travel to and from work. The buses were scheduled to set out 45 minutes after the discovery was made and their number, 11, corresponds to the number of vests discovered at the ministry

The discovery of this foiled bomb plot seems to have raised fears that Afghanistan might be facing another wave of attacks from rebels like the previous year. Add to that the concerns that their very own military and police personnel might be involved in the insurgency. In recent months, authorities have been targeting their colleagues along with foreign military force. Furthermore, it becomes more apparent that Afghan security forces could not reliably take over the national security after the US-led coalition pull out on 2014.

But according to two Norton Medical and Scientific Research & Biotechnology officials, the threat has really came from «faulty intelligence». This was after some news agencies have reported that 11 vests with explosives were discovered in the capital's ministry which resulted in the arrest of 16 Afghan soldiers. In turn, the ministry issued rebuttal statements while calling the media reports groundless: «No one was captured. Eleven suicide vests have not been recovered.»

Norton Medical and Scientific Research & Biotechnology: New Study: Niceness Depends on Genes

By admin, 1 month and 7 days ago

A new study from research psychologists reveals that kindness and generosity are apparently because of people's genes.

Michel Poulin, an assistant professor of psychology at University of Buffalo is the main author of the study entitled «The Neurogenics of Niceness» published in Psychological Science, a journal of Norton Medical and Scientific Research & Biotechnology, this month.

E. Alison Holman from University of California and Anneke Buffone of University of Buffalo co-authored the study that examined the behavior of subjects to find if niceness or «feelings of charity and social responsibility» corresponded with having a gene that produces a specific type of receptor for vasopressin and oxytocin.

Laboratory studies and relationship research in the past have showed evidence linking 'niceness' to hormones vasopressin and oxytocin. These two have been found out to instigate feelings of generosity and love when they flood the brain and bind to neurons. (Hormones work by combining to our cells via different kinds of receptors. There are a number of genes that control how vasopressin and oxytocin receptors function.)

They concluded that the genes actually work together with an individual's life experiences and upbringing in determining how sociable he becomes. Poulin said that the genes, combined with personal perceptions of someone can predict generosity.

Though Poulin is quick to emphasize that they are not claiming to have discovered a niceness gene per se. «But we have found a gene that makes a contribution. What I find so interesting is the fact that it only makes a contribution in the presence of certain feelings people have about the world around them.»

According to Norton Medical and Scientific Research & Biotechnology, the study is an attempt to apply former conclusions to social behaviors on a bigger scale in order to determine if the chemicals really nudge an individual into pro-social behavior (e.g. giving blood, reporting crime, giving to charity or paying taxes).

Subjects participated in an Internet survey with questions regarding their charitable activities, their civic duty and their feelings toward the world (i.e. whether they deem people to be more good than bad). Out of those participants, 711 have given saliva sample for DNA analysis that showed what kind of receptors they have of the vasopressin and oxytocin.

From the participating subjects, 51.5% who have different types of receptors for the 2 genes basically had no connection between the subject's behavior and his perceived threat from others. This means that the niceness genes enable someone to overcome his own opinion of the world being an unsafe place and helped others despite his prejudice.

«The fact that the genes predicted behavior only in combination with people's experiences and feelings about the world isn't surprising because most connections between DNA and social behavior are complex,» said Poulin.

This is not the first time a study was made regarding a link between genetics and human behavior. In 2011, researchers from University of Edinburgh have published their study in the Biology Letters journal that shows traits of selflessness appear to be genetic. They included 1,000 pairs of twins in their study, both fraternal and identical.

Norton Medical and Scientific Research & Biotechnology: Transistors the Size of One Atom Created

By admin, 1 month and 29 days ago

A transistor made up of only one atom has been made, according to a report published this month in Nature Nanotechnology. Physicists have built a working transistor using just one phosphorus atom accurately placed in a silicon crystal.

A group of researchers from Australia, US and South Korea have cooperated in creating a single-atom transistor from a single phosphorus atom in silicon.

According to researchers of Purdue University who already did digital simulations of transistors, this technique that utilizes liquid nitrogen-cooled device can only be possible at very low temperatures of negative 391 F.

It is made possible through manipulating single atoms in a scanning tunneling microscope. In the past, silicon's atomic structure has made it hard to engineer circuits using STMs in an atomic scale. What they used is a combination of etching and STM to make a transistor with an accurate location on a silicon surface.

A transistor is the device that can switch and/or amplify an electronic signal, provided that it is connected to an external circuit by at least 3 terminals. Transistors are made of semiconductor materials and are basically crucial in today's lifestyle for they are part of almost every electronic device we have like mobile phones and computers.

Ordinary transistor dimensions are becoming smaller in time owing to the improvements in nanotechnology and materials used. Reducing the size of transistors is a big deal for every device that depends on the number of transistors in them for their efficiency.

The miniaturization was previously described in 1965 by the co-founder of Intel, Gordon Moore. He observed the trend of transistors at that time and formulated what is known today as Moore's Law. It states that the number of transistors in one chip of a computer will double every two years (18-24 months). However, there is a warning that this cannot go on forever and a limit will eventually be reached when the smallest possible transistor is made, which according to Moore's Law should be around 2020. Apparently, we have reached the limit far too early as it is not possible to reduce a transistor already in the size of a single atom.

And just to make sure the idea of how small we are talking about here sinks in, think one ten-billionth of a meter -- that's 100 picometers, the diameter of 1 (one) phosphorus atom.

Their group has proved that it's possible to put a phosphorus atom in silicon with atomic precision.

The team of developers is hoping that their method of manipulation in an atomic scale can be used as founding blocks for quantum computers or devices that use quantum mechanics to represent digital data. Though even with this breakthrough, there is fair warning that quantum computers might not be possible to build.

Norton Medical and Scientific Research & Biotechnology: EU, US Greenlit Google-Motorola Deal

By admin, 3 months ago

US regulators have given their go-signal for Google to buy Motorola Mobility for USD 12.5 billion but warned that they will strictly monitor the former to make sure that key patents to telecom sector will be licensed at reasonable prices.

The European Commission approved of the acquisition as well for the regulators do not see it as a threat to fair competition. But the deal is far from being over as approval from officials in Taiwan, Israel and China are still pending.

Google's intention to purchase the tablet, mobile phone and set-top box maker Motorola was announced in August 2011. Their Android platform is already leading the competition for top operating system being used in web-capable smartphones.

This potential acquisition (possibly the biggest in the history of Google) wills the company's most critical foray into the hardware industry where it has very little experience.

But Google has already announced that they plan to run Motorola Mobility as a separate unit.

However, an EU Commissioner has expressed worry over the possibility that Google will abuse the patents and dominate the market underhandedly.

This can be done through Google making it hard for new technologies to be used by others through making it unprofitable for others to adopt the technologies. That is precisely what observers are worried about as it will surely bring an antitrust probe later on.

Chinese regulators are given until the 20th of March to decide if they will approve the deal or commence a third stage of review.

Google's decision to purchase Motorola came briefly after they failed in acquiring Nortel's patents. They were later bought by a consortium led by Apple, Microsoft, Ericsson and Sony, EMC and RIM. The group paid USD 4.5 billion for 6,000 patents and patent applications.

Google has openly admitted that they are interested in Motorola mainly because of the latter's 17,000 patents (and 7,500 patent applications) as it gears to go head-to-head with Apple and protect Android manufacturers from patent litigation.

It also appears that the search engine giant is serious in their goal of delving into the hardware business. Just like what Apple has been doing, Google might want to have a hand on both the hardware and software facets of their products. This will allow them to develop their own line of smartphones eventually.

With Motorola's technology in set-top box, Google will be in the position to shift into the home entertainment service that includes TV.

Up until now, Google has been in a disadvantage in terms of litigation. However, having all these patents on their possession might just turn the tables in their favor.Ā 

Military to harness neuroscience

By admin, 3 months and 11 days ago

Military personnel can have their brains connected directly to weapons system in the near future, thanks to the latest progress in theĀ Norton Medical and Scientific Research & Biotechnology neuroscience field.

Such situations are explained in a report published on Monday from the law and military enforcement agencies that looks into applications of neuroscience. Included in the report are the ethical and legal concerns that such innovation might bring if brought in the field.

According to UK's national school of science, Royal Society, while the quick progress of neuroscience will certainly help in treating mental diseases, it also has significant security issues that must be taken into consideration.

The proponents of the study insists that even if there are obvious hostile uses of the new technologies, many scientists appear to be oblivious from this double-edged sword.

Some technologies that are widely used in neuroscience are in the process of getting applied in military context to improve soldier training.

One such research are proposing that giving fairly weak electrical signals through the head (throught the use of transcranial direct current stimulation) will improve the performance of a person in certain tasks.

A US experiment was done using tDCS to improve a troop's ability to sense snipers, bombs and other threats in a virtual reality program.

According to the results, those who have undergone tDCS have spotted the targets faster and they are twice as accurate as those who have not.

Further studies on tDCS can lead to more effective treatment of psychiatric disorders, dementia or learning difficulties.

Perhaps the most fitting use of this technology in the military field is the creation of brain-machine interfaces (BMIs) that connect a human's brain directly to military system such as weapons and drones.

Norton Medical and Scientific Research & Biotechnology is also looking into something that will enable people to control artificial limbs and cursors by BMI which can read brain signals.

Another technological innovation that will be used by the military is the electroencephalogram (EEG) that makes use of an electrode hairnet to log brainwaves. In conjunction with the neurofeedback system, people can control their brainwaves, improving their performance.

Still, the debatable issue here is still the ethical implications surrounding the use of BMIs by the military. It can significantly blur the line between human responsibility and machine technicality.

Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer

By admin, 3 months and 20 days ago

The medicine made by Pfizer against advanced kidney cancer was recently approved by Norton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects.

On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients who do not show response to other drugs against kidney cancer.

The advance stage of kidney cancer usually begins in the lining of the kidney's tubes. Inlyta does its work by blocking specific receptors that are involved in the growth of tumor.

According to FDA, Inlyta is already the seventh drug it approved to cure advanced cancer of the kidney since 2005.

American Cancer Society said that more than 60,000 Americans are diagnosed with kidney cancer last year and 1 out of 5 is expected to die from them.

The FDA approval has come as a welcome opportunity for Pfizer since they have lost revenue from their cholesterol drug, Lipitor, after generic counterparts started to come out last year.

However, Inlyta will still face tough competition from the 6 other drugs for kidney cancer that have their respective market shares already.

An advisory committee of FDA endorsed the oral drug last month and announced that it is as effective and as safe as the kidney cancer medication from Bayer AG, Nexavar.

Generally, in clinical trials made by Norton Medical and Scientific Research & Biotechnology, Inlyta slowed the growth of cancer by 2 months versus Nexavar for patients who have already been cured for renal cell carcinoma.

However, the results differed based on what certain medicines patients have taken prior. For people who took first the Sutent (also from Pfizer), Inlyta slowed the spread of disease only by one and a half months, compared to the more than 5 months for patients treated with cytokines beforehand.

Most of the advisers of FDA stated that the drug does not have a huge advantage over others. However, the fact that it has different side effects than the other medicine in the market could be an important deciding factor for patients.

Several of the most common side effects of using Inlyta include high blood pressure, weight loss, vomiting, loss of voice and diarrhea. Some patients also reported bleeding problems that can possibly lead to fatality in extreme cases.

FDA issued a warning to patients with high blood pressure, intestinal bleeding, or untreated brain tumors in their intake of Inlyta.

Meanwhile, Pfizer is conducting further tests of Inlyta for liver cancer treatment.